Skip to main content

and
  1. Article

    Open Access

    Elucidating the mechanism of action of domatinostat (4SC-202) in cutaneous T cell lymphoma cells

    Targeting epigenetic modifiers is effective in cutaneous T cell lymphoma (CTCL). However, there is a need for further improvement of this therapeutic approach. Here, we compared the mode of action of romidepsi...

    Marion Wobser, Alexandra Weber, Amelie Glunz in Journal of Hematology & Oncology (2019)

  2. Article

    Open Access

    Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma

    Therapeutic vaccination directed to induce an anti-tumoral T-cell response is a field of extensive investigation in the treatment of melanoma. However, many vaccination trials in melanoma failed to demonstrate...

    Jürgen C. Becker, Mads H. Andersen in Cancer Immunology, Immunotherapy (2012)

  3. No Access

    Article

    Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression

    Recent reports have demonstrated that the enzyme indoleamine 2,3-dioxygenase (IDO) is upregulated in human dendritic cells (DCs) upon in vitro maturation. IDO is supposed to convey immunosuppressive effects by...

    Marion Wobser, Heike Voigt, Roland Houben in Cancer Immunology, Immunotherapy (2007)

  4. No Access

    Article

    Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin

    Purpose: As prognosis of advanced pancreatic cancer remains gloomy, novel therapeutic modalities have to be developed. Immunotherapy, which targets tumor-associated antigens of tumor cells or tumor stroma, is cur...

    Marion Wobser, Petra Keikavoussi, Volker Kunzmann in Cancer Immunology, Immunotherapy (2006)